Page
%P
-
Article
Open AccessA case with hepatic immune-related adverse events caused by nivolumab exhibiting impaired accumulation of regulatory T cells
Systemic administration of anti-programmed cell death 1 (PD-1) antibody (Ab) has achieved remarkable success in metastatic cancers. The blockade of PD-1-mediated signaling pathways sometimes cause immune-relat...